1. Involvement of miRNA-337 in Various Cancers
   Mahsa Fakeri et al, 2024, Current Cancer Therapy Reviews CrossRef
2. Biomarkers as Putative Therapeutic Targets in Colorectal Cancer
   Sonali Pal et al, 2021, Colon Cancer Diagnosis and Therapy CrossRef
3. Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression
   Lubna Tariq et al, 2023, Medical Oncology CrossRef
4. Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression
   Elmira Roshani Asl et al, 2021, Life Sciences CrossRef
5. MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression
   Cheng Wu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
6. Downregulation of miR‐337‐3p in hypoxia/reoxygenation neuroblastoma cells increases KCTD11 expression
   Lin Zhu et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
7. Pathophysiology roles and translational opportunities of miRNAs in colorectal cancer
   Petra Vychytilova-Faltejskova et al, 2022, MicroRNA in Human Malignancies CrossRef
8. Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS‐dependent manner 
   Sidi Dun et al, 2019, Journal of Biochemical and Molecular Toxicology CrossRef
9. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression
   Jeyalakshmi Kandhavelu et al, 2018, MicroRNA CrossRef
10. Emerging role of non-coding RNAs in the regulation of KRAS
    Soudeh Ghafouri-Fard et al, 2022, Cancer Cell International CrossRef
11. Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma
    Faheem Hyder Pottoo et al, 2021, Seminars in Cancer Biology CrossRef
12. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer
    Atena Soleimani et al, 2019, Journal of Cellular Biochemistry CrossRef
13. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications
    Ritu Shekhar et al, 2024, Targeting Signaling Pathways in Solid Tumors - Part B CrossRef